INDP

2.8209.90%
JD

Jerome D. Jabbour

Independent Director

Mr. Jerome D. Jabbour, J.D., also known as Jerry, is Independent Director of Indaptus Therapeutics, Inc. from February 26, 2026. Mr. Jabbour Co-founded Matinas BioPharma Holdings, Inc. and has been its Chief Executive Officer since March 16, 2018 and has been its President since March 7, 2016 and serves as Interim Chief Financial Officer since January 22, 2026. He serves as Chairman of Matinas BioPharma Holdings, Inc. since March 2025. Mr. Jabbour served as Executive Vice President, Chief Business Officer, General Counsel and Secretary of Matinas BioPharma Holdings, Inc. from October 2013 to March 7, 2016. He was the Executive Vice President and General Counsel of MediMedia USA, or MediMedia, from 2012 to October 2013, a privately held diversified health care services company. He Co-Founded Matinas Biopharma, Inc. Mr. Jabbour has extensive experience in the pharmaceutical and healthcare industries, both domestically and internationally. He served as Secretary of MediMedia. He was the Senior Vice President, Head of Global Legal Affairs of Wockhardt Limited (2008-2012), a global pharmaceutical and biotechnology company and Senior Counsel and Assistant Secretary at Reliant (2004-2008). Earlier in his career, he held positions as Commercial Counsel at Alpharma, Inc. (2003-2004) and as a Corporate Associate at Lowenstein Sandler LLP (1999-2003). He has been a Director of Matinas BioPharma Holdings, Inc. since March 16, 2018 and served as its Director from April 2012 until November 2013. He is Director of Matinas Biopharma, Inc. Mr. Jabbour earned his J. D. from Seton Hall University School of Law in Newark, New Jersey and a B. A. in Psychology from Loyola University in Baltimore, Maryland.

公司職務